Ribocure Pharmaceuticals AB
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING1
READOUTS ≤12 MONTHS3
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| RBD1016 NCT06649266 |
P2 | Active, not recruiting | Chronic Hepatitis D | 14 | 2026-09-24 (+4 mo) |
| RBD5044 NCT06797401 |
P2 | Recruiting | Dyslipidemias | 120 | 2027-05-31 (+12 mo) |
| Vortosiran NCT07850453 |
P2 | Not yet recruiting | Venous Thromboembolism (VTE); Cancer | 150 | 2027-07 |
| RBD1119 NCT07884136 |
P2 | Not yet recruiting | Stable Coronary Artery Disease | 200 | 2027-09-30 |
| Vortosiran NCT07870889 |
P2 | Not yet recruiting | Non-valvular Atrial Fibrillation (AF) | 150 | 2028-07-31 |